

Get in the KNOW
on LA Startups & Tech
XMeet the Startup That Wants To Deliver Ketamine to Your Door
David Shultz
David Shultz reports on clean technology and electric vehicles, among other industries, for dot.LA. His writing has appeared in The Atlantic, Outside, Nautilus and many other publications.
Ketamine is on the come up in the pharmaceutical world. Once confined to nightclubs and operating rooms, the drug is quickly gaining recognition as a valuable tool for treating mental health disorders including depression and anxiety.
Amid these rising tides, Wondermed has emerged, offering telehealth consultations and, potentially, the ability to deliver the drug right to your doorstep—all while building out a virtual platform and collecting data on how to use the molecule more effectively.
At the moment, the company provides a mail order service for courses of ketamine lozenges to those who’ve been prescribed the drug along with a telehealth software bridge between doctor and patient. Wondermed currently operates in five states — California, Texas, Florida, New York and Connecticut, though it plans to expand to another eight to 10 states in the next two weeks.
In the long run however, its plans are much bigger than being a link between doctors and patients.
“We generate more than 3,000 data points on every patient that comes into the funnel, and actually receives the medication,” says co-founder & Managing Director Jose Aycart.
His company is building out its online platform to collect and analyze patient data and provide mental health support services that may be useful, regardless of whether or not a patient is taking ketamine.
These data show in granular detail how ketamine therapies work. Does the route of administration matter? Does time of day matter? What types of patients are most likely to experience positive outcomes? It’s this data that represents the biggest business opportunity for Wondermed. The specifics of the monetization are still being worked out, but Aycart says it will never sell anonymized patient data to other companies.
Wondermed is in the midst of a seed funding round, targeting $7 million by the end of the month; It’s raised $5.6 million so far.
The company makes a bit of revenue by charging patients for consultations, but in the event that a patient doesn’t wind up using Wondermed’s platform, the consultation fee is refunded. For patients who are prescribed ketamine, the company charges only as much as the drugs cost them ($249 per month, which includes four doses), so neither Wondermed nor the physicians in its employ are incentivized to over-prescribe.
The drugs themselves are supplied by Tailor Made Compounding, a pharmacy in Nicholasville, Kentucky, and Wondermed is working on additional contracts in the pipeline with several other suppliers.
. Wondermed’s transformation comes as ketamine, which has typically been restricted to use as a general anesthetic, is quickly gaining recognition as a valuable tool for treating mental health disorders like depression and anxiety.
“What I’ve found interesting is how rapidly this field has emerged,” says Steven Grant, a drug and addiction researcher who spent 25 years at the National Institute on Drug Abuse and is now retired.

Ketamine is a simple organic molecule that first gained clinical popularity in the 1960s as an anesthetic. It produces a dissociative state in patients and dulls pain. Once in the bloodstream, the molecule travels to the brain where it binds to a protein called NMDA on the surface of neurons. NMDA has a variety of jobs, but it’s best-known for its role in learning, memory, and neuroplasticity—or the brain’s ability to form new pathways between neurons.
While the research into why ketamine is such an effective treatment for depression and anxiety is ongoing, the consensus so far is that the molecule’s power comes from this ability to rewrite or rewire the brain’s circuitry. If you’ve ever had an anxiety attack or a depressive episode, it can often feel like you’re stuck in a mental loop. Ketamine, it seems, offers a way to break that loop.
“It was this idea that you're increasing your neurological connections in the brain,” says Aycart. “You have the opportunity now to spark new forms of thought, new forms of emotion, or even new ideas.”
Unlike selective serotonin reuptake inhibitors (SSRIs) and other traditional drugs used to treat depression, ketamine’s effects are fast-acting—often appearing within minutes or hours of administration—and don’t require taking the drug daily.
“It really is revolutionary, and that’s why now more than ever, people are starting to get access to it, and companies like ourselves are really trying to bring it to people as an alternative form of medicine,” says Aycart.
Grant says the rise of ketamine clinics and telehealth services like Wondermed are likely a net positive because they increase patient access to drugs patients need, but he also has reservations about how the therapies are being applied.
Many of these psychoactive drugs—especially ketamine—are intended to be used in tandem with therapy, or at least under the supervision of a trained professional. Increasing the brain’s plasticity is a valuable tool for breaking out of depressive loops, but unless a professional is there to help the patient settle into a healthier mental pattern, the full benefits may be left on the table.
Wondermed offers a variety of supplementary support and strategies along with the drugs themselves, but taking advantage of these tools is left to the patient’s discretion. Grant would like to see a larger focus on extending and expanding that auxiliary support.
The company says it’s focused on building out the platform’s nonmedicinal mental health strategies—things like breathwork, meditation, music therapy—and adding them to an app. If they can get enough people on board, the eventual plan could be to sell health insights back to patients through a subscription model or something similar. They may even patent their own psychedelic molecules in the future. But all of this is likely quite a ways out.
“What we're trying to do is very new, and the landscape yet hasn't been built out,” says Aycart.
Clarification: This story has been updated to clarify Wondermed's monthly rate for ketamine lozenges.
From Your Site Articles
- Psychedelic Therapies Are Gaining Steam as Attitudes Change - dot ... ›
- Ketamine for Depression Is Now Available by Injection - dot.LA ›
- Ketamine Clinics Are Opening Across Los Angeles - dot.LA ›
- Pasithea Opens a Chic Clinic in Beverly Hills to Administer Ketamine - dot.LA ›
- New Pasithea Ketamine Clinic In Beverly Hills - dot.LA ›
- Pasithea Opens a Ketamine Clinic In Beverly Hills - dot.LA ›
Related Articles Around the Web
David Shultz
David Shultz reports on clean technology and electric vehicles, among other industries, for dot.LA. His writing has appeared in The Atlantic, Outside, Nautilus and many other publications.
JetZero Just Raised $175M to Rewrite How We Fly
07:06 AM | January 16, 2026
🔦 Spotlight
Happy Friday, Los Angeles ✈️
While everyone in tech is still busy arguing about the next AI model, one startup based out of Long Beach just raised a whole lot of money to change the shape of the airplane itself.

JetZero closed a $175 million Series B to build its blended wing body “all-wing” airliner, with B Capital leading the round alongside United Airlines Ventures, Northrop Grumman, 3M Ventures, Trucks VC and RTX Ventures. The company is working toward a full-scale Demonstrator aircraft that targets at least 30% better fuel efficiency than today’s tube-and-wing jets, with a first flight planned for 2027 and a commercial Z4 airliner to follow in the early 2030s.
This is not a small bet. JetZero’s pitch is that airlines and regulators need a way to hit climate targets without waiting on sci-fi batteries or hydrogen infrastructure, and that a radically more efficient airframe is the most realistic path. It is also very much an LA story: deep aerospace talent, strategic money at the table, and a product that looks like a mashup of climate tech, defense tech and old-school manufacturing rather than another SaaS dashboard.
There is still a long way to go. The next few years are about turning simulations and wind-tunnel charts into flight data, working with regulators and proving that a manta-ray-shaped jet can slot into a world built for Boeings and Airbuses. But if JetZero gets anywhere close, it will mean that one of the most ambitious hardware bets in commercial aviation is being engineered out of Long Beach.
Scroll on for the latest LA venture rounds, fund news and acquisitions.
🤝 Venture Deals
LA Companies
- No Agent List secured $10M in private investment to launch its AI powered real estate platform ahead of a planned Spring 2026 debut. The Los Angeles based company aims to put “agent level” tools directly in the hands of buyers, sellers and vendors, offering direct access to off market properties, FSBOs, distressed assets, foreclosures, tax liens and auctions that have traditionally been gated by agents and insiders. The funding will support product development and rollout of the platform, which promises more control over transactions while using AI to surface opportunities and streamline the deal process. - learn more
- Hadrian, the Los Angeles based advanced manufacturing startup, announced new capital led by accounts advised by T. Rowe Price Associates to accelerate its push to “reindustrialize” American manufacturing. The financing, which also includes Altimeter Capital, D1 Capital Partners, StepStone Group, 1789 Capital, Founders Fund, Lux Capital, a16z, Construct Capital and others, values the company at $1.6B and will be used to expand its high-throughput factories, grow its workforce and deploy more AI, software and automation across its “factories-as-a-service” platform for aerospace, defense and critical infrastructure customers.- learn more
LA Venture Funds
- Blue Bear Capital joined Hydrosat’s $60M Series B, backing the thermal infrared satellite data company alongside lead investors Hartree Partners, Subutai Capital Partners and Space 4 Earth. The funding will help Hydrosat expand its constellation beyond its two current satellites, ramp global coverage and deepen its AI-powered “thermal intelligence” products for water resource management, agriculture, civil government and defense customers worldwide. - learn more
- Elysian Park Ventures led a $12M growth round for Diamond Kinetics, backing the Pittsburgh-based baseball tech company as it doubles down on youth development. The new capital will help Diamond Kinetics scale sidelineHD, its AI-powered youth baseball and softball live streaming and highlights platform, and expand its broader suite of training tools as MLB’s Trusted Youth Development Platform. - learn more
- MANTIS Ventures participated in Depthfirst’s $40M Series A round, backing the San Francisco based applied AI lab alongside lead investor Accel, Alt Capital, BoxGroup, Liquid 2 Ventures and SV Angel. Depthfirst is building an AI-native “General Security Intelligence” platform that uses autonomous agents to detect, triage and remediate software vulnerabilities across code and infrastructure, aiming to outpace a new wave of AI-powered cyberattacks. The fresh capital will fund R&D, go-to-market efforts and hiring as the company scales its security platform for enterprise customers. - learn more
- Cedars-Sinai Health Ventures participated in Vista AI’s $29.5M Series B, joining a slate of leading health systems backing the company’s automated MRI scanning software. The Palo Alto-based startup will use the funding to expand its FDA-cleared cardiac MRI platform to additional anatomies like brain, prostate and spine, and to roll out remote scanning services that let hospitals without in-house MRI expertise offer advanced imaging while easing backlogs and technologist shortages - learn more
- Fourward Ventures is leading a new strategic growth investment in Mermaid Gin, backing the Isle of Wight–based premium spirits brand as it accelerates expansion in the U.S. market. The round brings Fourward’s founder Will Ward onto the board as lead investor and is paired with a national distribution partnership with Southern Glazer’s Wine & Spirits, plus the appointment of longtime Moët Hennessy veteran Jim Clerkin as CEO for the U.S. push. The capital and partnership are aimed at scaling Mermaid Gin in the fast-growing U.S. super-premium gin segment while preserving its sustainability-focused, Isle of Wight roots. - learn more
- Hyperion Capital joined Haiqu’s $11M seed round, backing the quantum software startup alongside Primary Venture Partners, Collaborative Fund, Alumni Ventures, Qudit Ventures, Silicon Roundabout Ventures, Harlow Capital, Toyota Ventures and MaC Venture Capital. Haiqu is building a hardware-aware quantum operating system and middleware layer that boosts the performance of today’s noisy quantum hardware, with the new funding going toward productizing its platform and enabling near-term commercial use cases in areas like finance, cybersecurity and scientific computing. - learn more
- Sound Ventures led WitnessAI’s $58M strategic funding round, backing the Mountain View based AI security and governance platform alongside investors including Fin Capital, Qualcomm Ventures, Samsung Ventures and Forgepoint Capital Partners. The company will use the capital to accelerate global go-to-market efforts and expand its platform, which secures AI agents and models by monitoring agent activity, linking human and agent actions, and blocking prompt injection and other attacks in real time. WitnessAI also unveiled new agentic AI governance tools that give enterprises deeper observability and policy control as they scale AI agents across their operations. - learn more
- Alexandria Venture Investments joined Proxima’s oversubscribed $80M seed financing, backing the newly rebranded AI-native biotech (formerly VantAI) alongside lead investor DCVC, NVentures (NVIDIA’s venture arm), Braidwell, Roivant and others. Proxima is building a generative AI driven platform for “proximity-based medicines” that modulate protein protein interactions, including molecular glues and PROTACs, to go after historically undruggable targets in oncology, immunology and beyond. The new capital will accelerate its NeoLink structural proteomics and Neo AI model stack, and advance a pipeline of first-in-class proximity-modulating therapeutics toward the clinic. - learn more
- Clocktower Technology Ventures participated in WeatherPromise’s oversubscribed $12.8M Series A, backing the weather-guarantee startup alongside lead investor Maveron, 1Sharpe, Lerer Hippeau, Commerce Ventures, MS Transverse, Start Ventures, 1Flourish and others. WeatherPromise partners with major travel brands like Marriott, Expedia and JetBlue to offer “weather guarantees” that automatically refund trips when conditions are worse than promised, driving demand for travel, events and outdoor experiences. The new capital will accelerate product development, expand strategic partnerships and scale the platform across more consumer categories. - learn more
- MANTIS Ventures participated in Sandstone’s $10M seed round, backing the AI-native legal tech startup alongside lead investor Sequoia Capital and others. Sandstone is building an operating system for in-house legal teams that uses AI agents to route requests, draft and review contracts, and surface answers directly inside tools like email, Slack and Salesforce, turning institutional legal knowledge into reusable workflows. The new capital will help the Brooklyn-based company scale its product and grow its customer base of corporate legal departments. - learn more
- Strong Ventures participated in Hupo’s $10M Series A round, backing the Singapore-based AI sales coaching startup alongside lead investor DST Global Partners, Collaborative Fund, January Capital and Goodwater Capital. Hupo’s platform uses AI to coach frontline banking, insurance and financial services sales teams in real time, helping them ramp faster and close more deals across highly regulated markets in APAC and Europe. The new funding will support product development, expansion of its coaching features and scaling enterprise deployments as the company eyes broader international growth. - learn more
- Freeflow Ventures joined Vivere Oncotherapies’ more than $10M funding round, backing the UC Berkeley spinout alongside YK Bioventures, Pillar, Berkeley Frontier Fund and the National Cancer Institute. Vivere is developing targeted immunotherapies for “cold” solid tumors like colorectal and ovarian cancers, aiming to activate the immune system against tumors that typically evade detection and resist existing treatments. The new capital will support advancement of its proprietary bioengineering platform and pipeline of therapies for patients with few effective options today. - learn more
- Alexandria Venture Investments joined Precede Biosciences’ $63.5M Series B equity round, part of an $83.5M total financing package that also includes a $20M strategic, non-dilutive credit facility. The Boston based precision diagnostics and data company is scaling its blood-based platform, which measures target expression and pathway activity to support next-generation cancer therapies like drug, radio and immune conjugates. The new capital will help Precede meet growing demand from biopharma partners developing these precision medicines and accelerate commercialization and health system adoption. - learn more
- Alexandria Venture Investments participated in Recludix Pharma’s new equity financing round alongside Access Biotechnology, NEA and Westlake BioPartners, with additional strategic investment from Eli Lilly. The San Diego based, clinical-stage biotech will use the $123M in total equity raised to advance clinical development of its novel SH2 domain inhibitor pipeline for inflammatory diseases and to tap Lilly’s TuneLab AI/ML platform to accelerate discovery across its broader SH2 domain program. - learn more
- BOLD Capital Partners participated in MagicCube’s $10M funding round, backing the Cupertino-based software security company alongside strategic investor Verifone and other existing backers. MagicCube plans to use the capital to expand beyond its core tap-to-phone payments offering into biometrics, identity verification and AI-driven device security, while scaling its Software Defined Trust platform that delivers hardware-grade protection through software on standard mobile and IoT devices.- learn more
LA Exits
- Webalo is being acquired by Prometheus Group, which is folding the Los Angeles based “no-code for the frontline” platform into its enterprise asset management software suite. The deal will combine Webalo’s mobile, real-time workflows for frontline workers with Prometheus Group’s planning and scheduling tools, aiming to create a closed-loop digital execution platform that connects shopfloor actions directly back into systems of record like SAP and Oracle. - learn more
Read moreShow less
LA Is Betting on Nukes, Netflix and Next-Gen Attention
11:30 AM | December 19, 2025
🔦 Spotlight
Hey Los Angeles.
If you were looking for a quiet week, this was not it. LA is backing a portable nuclear reactor, Netflix just took a big step closer to owning Warner Bros. Discovery’s future, and Snapchat is basically handing the city a mirror and saying, “Here is what you did with your attention all year.”
Let’s dive in.
Radiant’s microreactors and LA’s new nuclear moment
Radiant Nuclear raised more than $300M in a Series D round to build Kaleidos, a one megawatt portable nuclear microreactor that is designed to roll off a factory line, ship in a standard container and replace diesel generators at remote sites, military bases and disaster zones. The new capital will fund a full scale test at Idaho National Lab and the build out of Radiant’s R 50 factory in Oak Ridge, Tennessee, which aims to produce up to 50 reactors a year starting later this decade.
For LA’s climate and infrastructure ecosystem, this is a big tell. The city that got rich on pipelines of content is now funding pipelines of electrons, betting that small, modular nuclear can be part of the grid story that powers everything from data centers to defense. It is a very different flavor of LA tech, but the pattern is familiar: take a frontier technology, wrap it in product thinking and try to make it feel as boring and reliable as a utility bill.
Netflix and Warner Bros. Discovery: one step closer
On the media front, Netflix just received an official recommendation from Warner Bros. Discovery’s board to proceed with the planned acquisition of WBD’s studios and streaming business. The board reaffirmed that the Netflix deal, which would fold Warner Bros. film and TV, HBO and HBO Max into Netflix, is in the best interest of shareholders, even as competing ideas swirl around what to do with the company.
Practically, this does not mean the deal is done. It means the process has moved from “big idea in a press release” into the slower, more serious phase of shareholder approvals and regulatory review. For Los Angeles, every incremental step like this reinforces the likely end state: a world where a handful of global platforms control not just distribution but also the studios and libraries that defined Hollywood’s last century.
Snapchat’s 2025 Recap and the attention economy in our backyard
Then there is Snapchat, which used its 2025 Recap to show off what its mostly Gen Z and Gen Alpha users actually did on the app this year. The company is leaning into personalized “year in review” stories that highlight top chats, memories, maps moments and creator content, while quietly reminding brands and investors that Snap still owns a very specific slice of youth attention that is hard to find anywhere else.
For LA, Snapchat’s recap is more than a cute end of year product. It is a reminder that some of the most important social infrastructure for the next generation is being built and iterated a short drive from Santa Monica Boulevard. While the grown ups argue about nuclear reactors and studio mergers, Snap is training the next wave of consumers how to communicate, create and remember their lives on a platform that barely existed fifteen years ago.
Taken together, this week says a lot about what “LA tech” means in 2025. On one end, you have Radiant trying to change how we power the physical world. On the other, Netflix and Snapchat are fighting over how we package and monetize the stories that live in our heads. Somewhere in the middle are the founders, investors and operators here who see all of this as raw material.Now keep scrolling for this week’s LA venture deals, fund announcements and acquisitions.
🤝 Venture Deals
LA Companies
- Fixated secured a $50M strategic investment from Eldridge Industries to fuel what it calls the “next era of creator-led empires.” The company says the capital will help it expand its capabilities and partnerships that support creators in building and scaling their own brands and businesses beyond traditional sponsorship deals. - learn more
- Vital Lyfe raised $24M in financing, including more than $18M in seed funding, in a round led by Interlagos and General Catalyst with participation from Generational Partners, Cantos, Space.VC and Also Capital. The Hawthorne based startup, founded by former SpaceX engineers, will use the capital to ramp manufacturing of its portable, autonomous “water making” systems, expand early deployments with partners like maritime operators and NGOs, and prepare for its first consumer ready products in 2026. - learn more
- Molly Sims’ YSE Beauty closed a $15M Series A growth equity round led by Silas Capital, with participation from L Catterton and existing backers Willow Growth Partners and Halogen Ventures. The clinically tested skincare brand, which targets women 35+ and recently rolled out nationally at Sephora, will use the funding to fuel product development, expand across Sephora doors in the U.S., and grow its direct-to-consumer e-commerce business. - learn more
- Ember LifeSciences raised a $16.5M Series A led by Sea Court Capital, with participation from Cardinal Health, Carrier Ventures and other strategic investors including former U.S. Secretary of State Mike Pompeo. The Los Angeles based cold chain tech company will use the funding to launch its next generation Ember Cube 2 shipping system and expand globally, helping pharma and healthcare customers cut temperature related losses and waste in medicine distribution. - learn more
- Strada, a Los Angeles–based media collaboration startup, received a strategic investment from Other World Computing (OWC) to accelerate its product roadmap. The company’s peer-to-peer platform lets video pros access, share and review large files directly from local drives anywhere in the world, without uploading to the cloud. The partnership will also include co-marketing efforts, joint NAB 2026 presence, and bundled offerings that pair Strada’s software with OWC’s storage and workflow hardware. - learn more
LA Venture Funds
- Calibrate Ventures participated in Manifold’s Series B round, backing the company as it scales its AI technology platform. Manifold plans to use the new capital to accelerate product development, deepen its capabilities for enterprise customers, and grow its team to support broader commercial rollout. - learn more
- SmartGateVC participated in NeuraWorx’s oversubscribed seed round, which was led by Nexus NeuroTech to back the company’s neurotechnology based therapies for central nervous system (CNS) disorders. NeuraWorx plans to use the capital to advance its R&D and early clinical work, build out its technology and product pipeline, and expand its team as it moves toward bringing new CNS treatments to market. - learn more
- Kinship Ventures participated in Lovable’s $330M Series B, which values the Stockholm based “vibe coding” platform at $6.6B in a round co-led by CapitalG and Menlo Ventures’ Anthology fund. The company lets non developers build full stack software from natural language prompts, and says it will use the new capital to scale its AI native platform globally, deepen enterprise features and integrations, and support a fast growing base of business users building production apps on Lovable. - learn more
- B Capital participated in MoEngage’s $180M Series F follow-on, which brings the customer engagement platform’s total Series F raise to $280M. The round was led by ChrysCapital and Dragon Funds, with Schroders Capital and TR Capital also joining, and will be used to accelerate MoEngage’s Merlin AI product roadmap, expand go-to-market teams across North America and EMEA, and pursue strategic acquisitions while also funding an employee and early-investor liquidity program. - learn more
- O'Neil Strategic Capital led HEN Technologies’ $22M financing, which combines a $20M oversubscribed Series A with $2M in venture debt, to build what the company calls the industry’s first operating system for fire defense. The Hayward based startup will use the capital to scale its IoT enabled hardware and Fluid IQ predictive AI platform, capture a comprehensive operational fire dataset, and expand global deployments with distributors and agencies as it aims to make fire suppression faster, more efficient and data driven. - learn more
- Core Innovation Capital participated in Transparency Analytics’ second funding round, backing the company alongside lead investor Deciens Capital, Allianz Life Ventures, Mouro Capital, FJ Labs and SUM Ventures. Transparency Analytics, which provides quantitative, tech enabled credit ratings and benchmarking for private credit, will use the funding to scale its platform, refine go to market strategy and build out products like its private credit index as the asset class grows. - learn more
- Upfront Ventures participated in Nanit’s $50M growth round, which was led by Springcoast Partners with support from JVP. The company will use the funding to expand its AI powered Parenting Intelligence System and related tools that give parents real time, personalized insight into a baby’s sleep, health and development between pediatric visits. - learn more
- Integrity Growth Partners fully funded Fluency’s $40M Series A, coming in as the company’s first major institutional investor. Fluency, a “digital advertising operating system,” centralizes and automates paid media across Google, Meta, TikTok, programmatic and more, already powering nearly $3B in annual ad spend and over 250,000 monthly campaigns. The company plans to use the capital to enhance its automation and agentic AI capabilities, expand integrations with publishers and tech partners, and grow its team. - learn more
- JAM Fund joined Last Energy’s oversubscribed $100M+ Series C, backing the advanced nuclear startup as it pushes to commercialize its factory built microreactors. The round was led by Astera Institute with investors including Gigafund, The Haskell Company, AE Ventures, Ultranative, Galaxy Interactive and Woori Technology. Last Energy plans to use the capital to complete its PWR-5 pilot reactor under the U.S. DOE’s Reactor Pilot Program, ramp manufacturing in Texas, and advance its larger PWR-20 units toward commercial deployment in the U.S. and U.K. - learn more
LA Exits
- NextWave is being acquired by Pattern, bringing the TikTok-focused commerce agency under Pattern’s umbrella to strengthen its TikTok Shop and creator-led commerce capabilities. The deal folds NextWave’s expertise in TikTok Shop strategy, operations and creator partnerships into Pattern’s broader ecommerce platform, giving brands a single partner to manage marketplace, DTC and social shopping channels. - learn more
- Ubiquitous is being acquired by Humanz as part of Humanz’s broader push to build a next-gen, data driven creator economy platform alongside its recently announced $15M funding round. The deal folds Ubiquitous’ creator marketing and TikTok/native social expertise into Humanz’s influencer analytics and campaign tooling, giving brands a more end-to-end partner for strategy, creator management and performance measurement across major social channels. - learn more
- Silver Tribe Media is being acquired by TPG-backed Initial Group, which is folding the company into its broader sports and entertainment platform. The deal brings Silver Tribe’s storytelling, production and athlete brand work under Initial Group’s umbrella, giving it more capital and distribution while expanding Initial’s in-house content capabilities around teams, athletes and sponsors. - learn more
- Duffl, the YC-backed campus delivery startup, is being acquired by Rev Delivery, bringing its “10M campus delivery pioneer” operation under Rev’s umbrella. The acquisition folds Duffl’s college-focused, ultra-fast delivery network and playbook into Rev’s hyper-growth delivery operators, with the goal of scaling on-demand service across more campuses and strengthening Rev’s position in student-centered last-mile logistics. - learn more
Read moreShow less
RELATEDTRENDING
LA TECH JOBS


